tiprankstipranks
PHAXIAM Therapeutics (DE:2E4A)
FRANKFURT:2E4A

PHAXIAM Therapeutics (2E4A) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
0Neutral
15Bearish
Technical Analysis Consensus
Buy
7Bullish
0Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
PHAXIAM Therapeutics’s (2E4A) Moving Averages Convergence Divergence (MACD) indicator is -0.78, suggesting PHAXIAM Therapeutics is a Buy.
PHAXIAM Therapeutics’s (2E4A) 20-Day exponential moving average is 3.76, while PHAXIAM Therapeutics’s (2E4A) share price is €0.431, making it a Sell.
PHAXIAM Therapeutics’s (2E4A) 50-Day exponential moving average is 4.75, while PHAXIAM Therapeutics’s (2E4A) share price is €0.431, making it a Sell.

PHAXIAM Therapeutics (2E4A) Pivot Points

Mar 28, 2024, 08:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.40
0.41
0.42
0.43
0.44
0.45
0.46
Fibonacci
0.41
0.42
0.42
0.43
0.44
0.44
0.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PHAXIAM Therapeutics (2E4A) Moving Averages

Mar 28, 2024, 08:59 PM
Period
Simple
Exponential
MA5
2.59Sell
2.07Sell
MA10
3.48Sell
3.01Sell
MA20
4.15Sell
3.76Sell
MA50
4.77Sell
4.75Sell
MA100
6.24Sell
5.61Sell
MA200
6.39Sell
5.93Sell
PHAXIAM Therapeutics’s (2E4A) 10-Day exponential moving average is 3.01, while PHAXIAM Therapeutics’s (2E4A) share price is €0.431, making it a Sell.
PHAXIAM Therapeutics’s (2E4A) 100-Day exponential moving average is 5.61, while PHAXIAM Therapeutics’s (2E4A) share price is €0.431, making it a Sell.
PHAXIAM Therapeutics’s (2E4A) stock price is €0.431 and PHAXIAM Therapeutics’s (2E4A) 50-day simple moving average is 4.77, creating a Sell signal.
PHAXIAM Therapeutics’s (2E4A) stock price is €0.431 and PHAXIAM Therapeutics’s (2E4A) 100-day simple moving average is 6.24, creating a Sell signal.
PHAXIAM Therapeutics’s (2E4A) stock price is €0.431 and PHAXIAM Therapeutics’s (2E4A) 200-day simple moving average is 6.39, creating a Sell signal.

PHAXIAM Therapeutics (2E4A) Technical Indicators

Mar 28, 2024, 08:59 PM
Name
Value
Implied Action
RSI (14)
17.29
Buy
STOCH (9,6)
0.17
Buy
STOCHRSI (14)
0.17
Buy
MACD (12,26)
-0.78
Buy
ADX (14)
17.07
Buy
Williams %R
-99.75
Buy
CCI (14)
-312.63
Buy
ATR (14)
0.45
-
Ultimate Oscillator
11.47
Sell
ROC
-90.75
Sell
PHAXIAM Therapeutics’s (2E4A) Relative Strength Index (RSI) is 17.29, creating a Buy signal.
PHAXIAM Therapeutics’s (2E4A) Trend Strength Indicator (ADX) is 17.07, creating a Buy signal.
PHAXIAM Therapeutics’s (2E4A) Commodity Channel Index (CCI) is -312.63, creating a Buy signal.
PHAXIAM Therapeutics’s (2E4A) Price Rate of Change (ROC) is -90.75, creating a Sell signal.

FAQ

Is 2E4A a Buy, Hold, or Sell?
Based on 2E4A’s technical indicators, 2E4A is a Sell.
    What is 2E4A’s RSI (14)?
    2E4A’s RSI (14) is 17.29, which suggests 2E4A is a Buy.
      What is 2E4A’s MACD?
      2E4A’s MACD is -0.78, which suggests 2E4A is a Buy.
        What is 2E4A’s 5-day moving average?
        2E4A’s 5-day moving average is 2.59, which suggests 2E4A is a Sell.
          What is 2E4A’s 20-day moving average?
          2E4A 20-day moving average is 4.15, which suggests 2E4A is a Sell.
            What is 2E4A’s 50-day moving average?
            2E4A’s 50-day moving average is 4.77, which suggests 2E4A is a Sell.
              What is 2E4A’s 200-day moving average?
              2E4A’s 200-day moving average is 6.39, which suggests 2E4A is a Sell.
                What is 2E4A’s Williams % R (14)?
                2E4A’s Williams % R (14) is -99.75, which suggests 2E4A is a Buy.
                  What is 2E4A’s CCI (14)?
                  2E4A’s CCI (14) is -312.63, which suggests 2E4A is a Buy.
                    What is the share price of PHAXIAM Therapeutics?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis